“The FDA has approved a new treatment for chronic hepatitis B that can allow some patients to stop long-term antiviral medication. After a 24-week course of the new drug alongside existing antivirals, followed by another 24 weeks on antivirals alone, 19 percent of recipients across two trials still had no detectable virus six months after stopping all treatment. Chronic hepatitis B typically requires years of antiviral treatment, sometimes for life, to keep the virus under control.”
Hepatitis B is the most common type of hepatitis worldwide. About 300 million people are infected globally, most of them in sub-Saharan Africa and Southeast Asia.
Read Full Article: https://libertyunyielding.com/2026/11/03/new-treatment-for-hepatitis-b/
